Leflunomide Treatment for MEN1 Patients - the LUMEN1 Trial

NCT05605587 · clinicaltrials.gov ↗
NA
Phase
TERMINATED
Status
3
Enrollment
OTHER
Sponsor class

Stopped The study was prematurely terminated due to significant difficulties in recruiting participants, arising from the extremely rare nature of the targeted gene mutation.

Conditions

Interventions

Sponsor

University Hospital, Basel, Switzerland